Navinci is a Swedish biotech company that specializes in developing innovative solutions for the study of protein interactions. With a focus and a strong legacy in the development of in situ proximity ligation assay technology, Navinci has established itself as a center of excellence in the field and has a broad portfolio of products that help researchers study protein interactions in depth. Our Naveni Proximity Ligation Technology is at the forefront of innovation within the field of spatial proteomics and allows for the detection and quantification of protein interactions and post-translational modifications in a manner that is both sensitive and specific. It provides researchers with a valuable tool for their studies and helps deepen the understanding of the interplay between proteins in their native environment. Our latest focus is on target-specific kits within immuno-oncology, which detect interactions such as PD1/PD-L1. These kits are designed to help researchers easily visualize the interactions between immune checkpoint proteins in immune and cancer cells and elucidate the role that interactions, rather than individual proteins, play in the development of cancer. By providing researchers with reliable and innovative tools for visualizing and interpreting protein interplay, Navinci pushes forward the understanding of cell biology and brings precision to spatial proteomics.
Extern länk för Navinci Diagnostics
Dag Hammarskjölds väg
52A
Uppsala, Uppsala County 75237, SE
Navinci Diagnostics omdelade detta
Canopy Spatial Services is thrilled to announce our partnership with Navinci Diagnostics to offer their isPLA technology using our CellScape platform! Pair investigation of protein-protein interactions with high-plex targeted spatial proteomics to characterize tumor microenvironments in unprecedented detail. See the interactions specific to YOUR research with NaveniFlex. You pick the targets, we will handle the work.
New partnership announcement 🚨 We are excited to have teamed up with Canopy Biosciences, who can now offer our in situ proximity ligation assays, enabling precise detection of proteins, protein-protein interactions, or protein modifications, to their CRO customers. Canopy can also intergrate Navinci’s technology with their CellScape platform, combining our protein interaction data with high-plex targeted spatial proteomics. Read more here: https://lnkd.in/e4Dbhera
We are pleased to announce the strengthening of our leadership team with the appointment of Sopana Leife as Director of Operations for Navinci, effective 2nd September 2024. Sopana brings with her extensive experience in the life sciences field, and we are thrilled to have her driving operational excellence and supporting our continued growth. Read more here: https://lnkd.in/g24qzNqU
TOMORROW! Don't miss out on our webinar with Leica Biosystems, presented by Navinci's Application Scientist Dr Doroteya Raykova Learn how to use Navinci's in situ proximity ligation assay in a fully automated manor on BOND RX/RXm automated research stainer to save you time, reduce data variability, and provide valuable insights into protein-protein interactions, helping you illuminate function in spatial proteomics! 📅 Date: September 4, 2024 🕗 Time: 8 AM PDT | 11 AM EDT Register now to join live or to receive the recording after: https://ow.ly/qLmT50SOEeC For Research Use Only. Sponsored by Leica Biosystems.
One week to go, don't forget to register! 📢 Next Wednesday, September 4th, we are hosting a webinar with our application scientist, Dr. Doroteya Raykova Discover how our innovative in situ proximity ligation technology can provide highly sensitive detection of protein-protein interactions, post-translational modifications, and single protein expression in cells and tissues. Then, find out how to get these results in a robust, high-throughput, fully automated manner on the BOND RX/RXm automated research stainer by Leica Biosystems, saving hands-on time and reducing data variability. 📅 Date: September 4, 2024 🕗 Time: 8 AM PDT | 11 AM EDT Register now to join live or to receive the recording after: https://ow.ly/qLmT50SOEeC For Research Use Only. Sponsored by Leica Biosystems.
Live webinar! Learn how to use in situ proximity ligation assay (isPLA) automated on BOND RX/RXm automated stainer. Our application scientist Doroteya Raykova will demonstrate how this advanced technology can save you time, reduce data variability, and provide valuable insights into protein-protein interactions, helping you illuminate function in spatial proteomics! 📅 Date: September 4, 2024 🕗 Time: 8 AM PDT | 11 AM EDT Register now and explore the future of spatial interactomics! Follow link below 👇 For Research Use Only.
Join us for a live webinar with Dr. Doroteya Raykova from Navinci Diagnostics on September 4, 2024! Discover Navinci's innovative in situ proximity ligation technology (isPLA) for highly sensitive detection of protein-protein interactions, post-translational modifications, and single protein expression in cells and tissues. Learn how these new levels of information can now be obtained in a robust, high-throughput, fully automated manner on our BOND RX/RXm automated stainer, saving hands-on time and reducing data variability. 📅 Date: September 4, 2024 🕗 Time: 8 AM PDT | 11 AM EDT Register now and explore the future of spatial interactomics! https://ow.ly/qLmT50SOEeC For Research Use Only.
Final throwback to AACR ☀ To wrap up our series looking back at the highlights of AACR, we have Dr Arutha Kulasinghe presenting the work of his group at The University of Queensland, where they performed spatial profiling on Akoya Biosciences, Inc.’s Phenocycler Fusion with Navinci’s isPLA technology, enabling the idetification of 'immune cell rivers' of interactions in the TME. Watch Arutha's presentation below, and follow the link to read more and view the whole poster: https://lnkd.in/e9VwDjWv American Association for Cancer Research
Time for another throwback to AACR ☀ Presented by Tony Ullman, Dr Charlotte Stadler’s group at SciLifeLab-KTH Royal Institute of Technology used Navinci’s in situ PLA to explore the PD-1/PD-L1 interaction as part of a multiplex IF panel, with the aim to deep-phenotype the tumor microenvironment. Watch Tony’s presentation below, and take a look at the full poster and read more here: https://lnkd.in/eTTDDugp American Association for Cancer Research
🚨 Navinci in the spotlight 🚨 Our Chief Business Officer, Subham Basu, has been featured in Biocompare's latest article 'From Cold to Hot: Immunophenotyping Tumors and Their Microenvironments' Subham's insights into the role of immunophenotyping in cancer research highlight the innovative work we're doing at Navinci to advance precision medicine by improving spatial biology biomarkers Read the article here: https://lnkd.in/gDS6Mtbz
Another edition of our throwback to AACR series ☀ In collaboration with Canopy Biosciences, this poster, presented by Dr Arne Christians, demonstrates how high resolution imaging of immune checkpoint activation using Navinci’s in situ PLA technology and precise spatial multiplexing on the Canopy CellScape Platform uncovers differential tumor-immune cell regulation in cancer tissues. Watch Arne’s presentation below, and follow the link to read more and view the poster: https://lnkd.in/e-qY2_rt American Association for Cancer Research
Senaste finansieringsrunda
Serie A8 503 995,00 US$